Kyowa Kirin Co., Ltd.
Notice Regarding Partial Amendments to the Articles of Incorporation
Kyowa Kirin Co., Ltd. plans to propose partial amendments to the Articles of Incorporation at the Annual General Meeting of Shareholders scheduled for March 19, 2026, aimed at adding new business purposes and transitioning to a company with an audit and supervisory committee.
Key Figures
- Effective Date of Articles Amendment: 2026-03-19 (Scheduled)
- Number of Directors (excluding Audit and Supervisory Committee members): Up to 10
- Number of Directors who are Audit and Supervisory Committee Members: Up to 5
AI要約
Overview of Amendments to the Articles of Incorporation
Kyowa Kirin Co., Ltd. will add “Manufacture, import/export, and sale of regenerative medicine products, etc.” as a new business purpose to Article 3 (Purpose) of the current Articles of Incorporation to accommodate business expansion. Additionally, the Company will transition to a company with an audit and supervisory committee to strengthen oversight functions of the Board of Directors by deleting provisions related to statutory auditors and the board of statutory auditors and newly establishing provisions related to the audit and supervisory committee. Concurrently, changes will be made to regulations concerning the number of directors and delegation of important business execution decisions.
Shareholders Meeting and Future Outlook
The amendments to the Articles of Incorporation will be proposed at the 103rd Annual General Meeting of Shareholders scheduled for March 19, 2026, and are expected to become effective on the same day upon approval. By transitioning to a company with an audit and supervisory committee, the Board of Directors aims to focus on medium to long-term and broad strategic discussions and establish a swift and decisive decision-making system. This is expected to enhance corporate governance and reinforce risk management.
